US stocks struggled gained steam on Thursday afternoon as investors digested megacap tech earnings and waited for Apple (AAPL ...
Teva Pharmaceutical's Q4 2024 results were strong, but 2025 guidance underwhelmed, causing a sharp stock sell-off. See why I ...
Some of the most reliable millionaire-maker stocks are well-established companies with year after year of revenue growth and ...
Apple's earnings call is today at 5 pm ET. AAPL stock heads into the report down 4% YTD. Analysts are focused on services and ...
IBM (NYSE: IBM) stock has surged significantly in after-hours trading by 10% and 9% in pre-market trading. This is due to IBM reporting solid Q4 2024 results and bullish guidance for 2025. Here’s ...
Microsoft is the worst Dow Jones stock Thursday as the tech giant's soft outlook offsets an earnings beat. Here's what you need to know.
Cardinal Health had $210 billion in pharmaceutical and specialty drugs sales in fiscal 2024, up 11% year-over-year, helped in large part by GLP-1 sales. In Q4, segment sales rose 13% to $55 billion, ...
The pace of economic growth slowed slightly during the fourth quarter. But all things considered, it was still a pretty strong report, suggesting that a robust economy should continue to boost stocks ...
Investors punished Microsoft with a 6% share drop on Thursday as hefty AI bets failed to drive a big increase in its cloud ...
Follow along for live updates on stocks, bonds and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.
Tesla, Inc.'s Q4 earnings show revenue stagnation and declining margins in the automotive division. Read more on TSLA stock ...
IBM stock, with 45% returns since the beginning of 2024, has outperformed the S&P 500 index, up 27%. Strong demand trends for its software business has driven its stock price growth lately. But, if ...